Does SPIRONOLACTONE Cause Interstitial lung disease? 80 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Interstitial lung disease have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.4% of all adverse event reports for SPIRONOLACTONE.
80
Reports of Interstitial lung disease with SPIRONOLACTONE
0.4%
of all SPIRONOLACTONE reports
3
Deaths
71
Hospitalizations
How Dangerous Is Interstitial lung disease From SPIRONOLACTONE?
Of the 80 reports, 3 (3.8%) resulted in death, 71 (88.8%) required hospitalization, and 14 (17.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 80 reports have been filed with the FAERS database.
What Other Side Effects Does SPIRONOLACTONE Cause?
Acute kidney injury (3,273)
Hyperkalaemia (2,518)
Hypotension (1,583)
Dyspnoea (1,468)
Drug ineffective (1,379)
Hyponatraemia (1,166)
Dizziness (991)
Fatigue (990)
Fall (947)
Off label use (899)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SPIRONOLACTONE Alternatives Have Lower Interstitial lung disease Risk?
SPIRONOLACTONE vs SPRYCEL
SPIRONOLACTONE vs STALEVO
SPIRONOLACTONE vs STANNOUS FLUORIDE
SPIRONOLACTONE vs STANOZOLOL
SPIRONOLACTONE vs STAVUDINE